The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Factors controlling the activity of the SERCA2a pump in the normal and failing heart
Abstract
Heart failure is the leading cause of death in western countries and is often associated with impaired Ca 2+ handling in the cardiomyocyte. In fact, cardiomyocyte relaxation and contraction are tightly controlled by the activity of the cardiac sarco(endo)plasmic reticulum (ER/SR) Ca 2+ pump SERCA2a, pumping Ca 2+ from the cytosol into the lumen of the ER/SR. This review addresses three important facets that control the SERCA2 activity in the heart. First, we focus on the alternative splicing of the SERCA2 messenger, which is strictly regulated in the developing heart. This splicing controls the formation of three SERCA2 splice variants with different enzymatic properties. Second, we will discuss the role and regulation of SERCA2a activity in the normal and failing heart. The two well‐studied Ca 2+ affinity modulators phospholamban and sarcolipin control the activity of SERCA2a within a narrow window. An aberrantly high or low Ca 2+ affinity is often observed in and may even trigger cardiac failure. Correcting SERCA2a activity might therefore constitute a therapeutic approach to improve the contractility of the failing heart. Finally, we address the controversies and unanswered questions of other putative regulators of the cardiac Ca 2+ pump, such as sarcalumenin, HRC, S100A1, Bcl‐2, HAX‐1, calreticulin, calnexin, ERp57, IRS‐1, and −2. © 2009 International Union of Biochemistry and Molecular Biology, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A growing body of evidence indicates that HAX-1 binds SERCA either independently or in conjunction with PLN [25, 26, 33–36].”
From Intrinsically disordered HAX-1 regulates Ca2+ cycling by interacting with lipid membranes and the phospholamban cytoplasmic region (2020) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Donato, R. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00046-2 · Cited by 1,580
HITS-CLIP yields genome-wide insights into brain alternative RNA processing
Licatalosi, D. D., Mele, A., Fak, J. J., Ule, J., Kayikci, M., Chi, S. W., Clark, T. A., Schweitzer, A. C., Blume, J. E., Wang, X., et al. (2008) · Nature · doi:10.1038/nature07488 · Cited by 1,352 · cited 1×
“It is further believed that embryological development and the progressive stages of cell differentiation are accompanied by the successive expression of alternative splicing factors, each coordinately regulating a wave of different alternative splicing events [20,21].”
BackgroundStructural biology of the Bcl-2 family of proteins
Petros, A. M., Olejniczak, E. T., & Fesik, S. W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.08.012 · Cited by 745
Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease
Sakuntabhai, A., Ruiz-Perez, V., Carter, S., Jacobsen, N., Burge, S., Monk, S., Smith, M., Munro, C. S., O'Donovan, M., Craddock, N., et al. (1999) · Nature Genetics · doi:10.1038/6784 · Cited by 740
Boutz, P. L., Stoilov, P., Li, Q., Lin, C.-H., Chawla, G., Ostrow, K., Shiue, L., Ares, M., & Black, D. L. (2007) · Genes & Development · doi:10.1101/gad.1558107 · Cited by 577
A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart
Kalsotra, A., Xiao, X., Ward, A. J., Castle, J. C., Johnson, J. M., Burge, C. B., & Cooper, T. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809045105 · Cited by 508 · cited 1×
“It is further believed that embryological development and the progressive stages of cell differentiation are accompanied by the successive expression of alternative splicing factors, each coordinately regulating a wave of different alternative splicing events [20,21].”
BackgroundJaski, B. E., Jessup, M. L., Mancini, D. M., Cappola, T. P., Pauly, D. F., Greenberg, B., Borow, K., Dittrich, H., Zsebo, K. M., & Hajjar, R. J. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.01.013 · Cited by 457
Schwinger, R. H. G., Böhm, M., Schmidt, U., Karczewski, P., Bavendiek, U., Flesch, M., Krause, E.-G., & Erdmann, E. (1995) · Circulation · doi:10.1161/01.cir.92.11.3220 · Cited by 395
del Monte, F., Williams, E., Lebeche, D., Schmidt, U., Rosenzweig, A., Gwathmey, J. K., Lewandowski, E. D., & Hajjar, R. J. (2001) · Circulation · doi:10.1161/hc3601.095574 · Cited by 382
MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development
Boutz, P. L., Chawla, G., Stoilov, P., & Black, D. L. (2007) · Genes & Development · doi:10.1101/gad.1500707 · Cited by 304
Research works printed but not linked: 187
- 10.1038/nrm1155 · DOI · Paper page
- 10.1016/j.bbamcr.2004.08.012 · doi:10.1016/j.bbamcr.2004.08.012
- 10.1002/mus.20745 · DOI · Paper page
- 10.1016/j.ceca.2005.06.033 · DOI · Paper page
- 10.1006/jmcc.2001.1366 · DOI · Paper page
- Lytton J., 1988, Molecular cloning of cDNAs from human kidney coding for two alternatively spliced products of the cardiac Ca2+‐ATPase gene, J. Biol. Chem., 263, 15024, 10.1016/S0021-9258(18)68141-4 · DOI · Paper page
- 10.1016/S0143-4160(03)00126-X · doi:10.1016/s0143-4160(03)00126-x
- 10.1042/BJ20051427 · DOI
- 10.1016/j.ceca.2008.08.002 · DOI
- 10.1074/jbc.M314286200 · DOI
- 10.1016/S0006-8993(96)01037-2 · doi:10.1016/s0006-8993(96)01037-2
- 10.1016/j.tcb.2009.03.006 · DOI
- 10.1074/jbc.273.22.13982 · doi:10.1074/jbc.273.22.13982
- 10.1074/jbc.270.18.11004 · doi:10.1074/jbc.270.18.11004
- 10.1042/bj3220885 · doi:10.1042/bj3220885
- 10.1016/S0006-291X(03)00405-4 · DOI
- 10.1016/S0165-3806(98)80015-6 · DOI
- 10.1038/nsmb0109-13 · DOI
- 10.1007/s003350010030 · DOI
- 10.1016/j.ceca.2004.06.003 · DOI
- 10.1152/ajpheart.00545.2005 · DOI
- 10.1038/nsmb.1552 · DOI · Paper page
- 10.1042/bj3030979 · doi:10.1042/bj3030979
- Vandecaetsbeek I., Structural basis for the high Ca2+ affinity of the ubiquitous SERCA2b Ca2+ pump, Proc. Natl. Acad. Sci. USA
- 10.1139/y06-023 · doi:10.1139/y06-023
- 10.1016/j.ceca.2006.04.004 · DOI
- 10.1016/j.yjmcc.2009.03.013 · DOI
- 10.1006/jmcc.1994.1064 · DOI
- 10.1161/hh2101.098466 · DOI
- 10.1016/j.yjmcc.2006.05.014 · doi:10.1016/j.yjmcc.2006.05.014
- 10.1038/nrm1151 · DOI · Paper page
- 10.1073/pnas.0237326100 · DOI · Paper page
- 10.1016/j.bbamcr.2006.08.025 · DOI
- 10.1016/j.yjmcc.2007.03.738 · DOI
- 10.1093/cvr/cvm056 · DOI · Paper page
- 10.1074/jbc.M213132200 · DOI
- 10.1042/BJ20050068 · DOI
- 10.1016/j.yjmcc.2007.05.009 · DOI
- 10.1074/jbc.C200269200 · DOI
- 10.1073/pnas.0402596101 · DOI
- 10.1074/jbc.M508998200 · DOI
- 10.1073/pnas.0330962100 · DOI · Paper page
- 10.1016/j.cardiores.2004.08.012 · DOI
- 10.1073/pnas.0510883103 · DOI
- 10.1073/pnas.0707722104 · DOI
- 10.1023/A:1017945810355 · doi:10.1023/a:1017945810355
- 10.1016/j.yjmcc.2009.07.014 · DOI
- Morgan J. P., 1990, Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure, Circulation, 81, III21
- 10.1161/01.CIR.85.3.1046 · DOI · Paper page
- 10.1161/01.RES.75.3.434 · DOI · Paper page
- 10.1161/01.CIR.90.2.653 · DOI · Paper page
- 10.1006/jmcc.1998.0897 · DOI · Paper page
- 10.1152/ajpheart.00442.2003 · doi:10.1152/ajpheart.00442.2003
- 10.1016/j.cardiores.2003.11.005 · DOI
- 10.1126/science.1081578 · DOI · Paper page
- 10.1073/pnas.0510519103 · DOI · Paper page
- 10.1172/JCI118446 · DOI · Paper page
- 10.1161/01.CIR.103.6.889 · DOI
- 10.1074/jbc.M102403200 · DOI
- 10.1016/S0008-6363(02)00541-2 · DOI
- 10.1007/s11248-007-9139-2 · DOI
- 10.1074/jbc.274.4.2556 · DOI · Paper page
- 10.1136/hrt.2004.051037 · DOI
- 10.1046/j.1365-2230.2001.00921.x · DOI
- 10.1074/jbc.C100275200 · DOI
- 10.1113/jphysiol.2002.026732 · DOI
- 10.1161/hc0802.105564 · DOI · Paper page
- 10.1161/01.CIR.100.23.2308 · DOI · Paper page
- 10.1073/pnas.97.2.793 · DOI · Paper page
- 10.1161/01.CIR.100.9.974 · DOI
- 10.1161/CIRCULATIONAHA.108.783852 · DOI · Paper page
- 10.1038/nm739 · DOI · Paper page
- 10.1172/JCI18716 · DOI · Paper page
- 10.1161/01.RES.75.3.401 · DOI · Paper page
- Nakayama H., 2003, Cardiac‐specific overexpression of a high Ca2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy, FASEB J., 17, 61, 10.1096/fj.02-0474fje · doi:10.1096/fj.02-0474fje
- 10.1016/j.cardiores.2005.04.029 · DOI
- 10.1161/01.RES.0000161256.85833.fa · DOI · Paper page
- 10.1016/j.yjmcc.2009.05.010 · DOI
- 10.1096/fj.05-5299fje · DOI
- 10.1093/cvr/cvn113 · DOI
- 10.1093/cvr/cvn208 · DOI
- 10.1161/01.RES.0000069032.81501.98 · DOI
- 10.1016/j.ceca.2007.01.001 · DOI
- 10.1016/S0021-9258(19)49738-X · DOI · Paper page
- 10.1074/jbc.M004804200 · DOI
- 10.1038/nm1000 · DOI · Paper page
- 10.1172/JCI17892 · DOI · Paper page
- 10.1152/ajpheart.00272.2008 · DOI
- 10.1161/CIRCULATIONAHA.105.583351 · DOI
- 10.1016/S0092-8674(00)81878-4 · DOI · Paper page
- 10.1016/j.yjmcc.2005.12.002 · DOI
- 10.1006/bbrc.1997.7539 · doi:10.1006/bbrc.1997.7539
- 10.1016/S0008-6363(01)00346-7 · DOI
- 10.1016/S0008-6363(98)00241-7 · DOI
- 10.1172/JCI200316738 · DOI
- 10.1161/CIRCULATIONAHA.108.783506 · DOI
- 10.1111/j.0742-2822.2004.03083.x · doi:10.1111/j.0742-2822.2004.03083.x
- 10.1016/j.jcmg.2008.04.012 · DOI
- 10.1161/01.RES.0000066661.49920.59 · doi:10.1161/01.res.0000066661.49920.59
- 10.1074/jbc.M001569200 · DOI
- 10.1073/pnas.68.6.1231 · DOI · Paper page
- 10.1073/pnas.86.16.6047 · DOI
- 10.1016/j.pbiomolbio.2003.07.001 · DOI · Paper page
- Leberer E., 1990, Purification, calcium binding properties, and ultrastructural localization of the 53,000‐ and 160,000 (sarcalumenin)‐dalton glycoproteins of the sarcoplasmic reticulum, J. Biol. Chem., 265, 10118, 10.1016/S0021-9258(19)38787-3 · doi:10.1016/s0021-9258(19)38787-3
- Szegedi C., 1999, Calsequestrin: more than ‘only’ a luminal Ca2+ buffer inside the sarcoplasmic reticulum, Biochem. J., 337, 19, 10.1042/bj3370019 · doi:10.1042/bj3370019
- 10.1074/jbc.M406618200 · DOI
- 10.1093/cvr/cvm019 · doi:10.1093/cvr/cvm019
- 10.1152/ajpheart.00278.2007 · DOI
- 10.1007/BF01766464 · doi:10.1007/bf01766464
- 10.1113/jphysiol.2009.172171 · DOI
- Hofmann S. L., 1989, Molecular cloning of a histidine‐rich Ca2+‐binding protein of sarcoplasmic reticulum that contains highly conserved repeated elements, J. Biol. Chem., 264, 18083, 10.1016/S0021-9258(19)84681-1 · DOI
- 10.1016/0006-291X(92)90797-O · doi:10.1016/0006-291x(92)90797-o
- 10.1016/S0143-4160(97)90113-5 · DOI
- 10.1006/jmcc.2001.1394 · DOI · Paper page
- 10.1152/ajpheart.01211.2003 · DOI
- Gregory K. N., 2006, Targeting sarcoplasmic reticulum calcium handling proteins as therapy for cardiac disease, Hellenic J. Cardiol., 47, 132
- 10.1111/j.1432-1033.1988.tb13805.x · DOI
- 10.1152/ajpregu.00075.2007 · DOI
- 10.2741/heizmann · DOI · Paper page
- 10.1016/S0925-4439(99)00106-4 · DOI
- 10.1016/0167-4889(96)00097-3 · DOI · Paper page
- 10.1128/MCB.22.8.2821-2829.2002 · DOI
- 10.1016/S0006-291X(03)00987-2 · DOI
- 10.1172/JCI21454 · doi:10.1172/jci21454 · Paper page
- 10.1016/0092-8674(91)90361-2 · DOI · Paper page
- 10.1152/ajpcell.00229.2006 · DOI · Paper page
- 10.1006/jmcc.2001.1498 · DOI · Paper page
- 10.1016/S0002-8703(03)00445-9 · DOI
- 10.1016/S0735-1097(00)00647-1 · DOI
- 10.1111/j.1440-1681.2009.05243.x · DOI
- 10.1007/s10495-008-0302-x · DOI · Paper page
- Lithgow T., 1994, The protein product of the oncogene bcl‐2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane, Cell Growth Differ., 5, 411
- 10.1182/blood.V88.2.386.bloodjournal882386 · DOI · Paper page
- 10.1126/science.1083628 · DOI · Paper page
- 10.1073/pnas.97.11.5723 · DOI · Paper page
- 10.1083/jcb.148.5.857 · DOI · Paper page
- 10.1038/sj.emboj.7600104 · DOI · Paper page
- 10.1038/sj.onc.1207519 · DOI
- 10.1038/sj.onc.1202110 · DOI · Paper page
- 10.1042/BJ20040187 · DOI
- 10.1021/bi050800s · DOI
- Tanaka S., 1993, Structure‐function analysis of the Bcl‐2 oncoprotein. Addition of a heterologous transmembrane domain to portions of the Bcl‐2 beta protein restores function as a regulator of cell survival, J. Biol. Chem., 268, 10920, 10.1016/S0021-9258(18)82073-7 · DOI · Paper page
- 10.1016/0092-8674(93)80066-N · DOI · Paper page
- 10.4049/jimmunol.158.6.2736 · DOI · Paper page
- 10.1007/s00424-008-0506-5 · DOI · Paper page
- 10.1016/j.jmb.2006.10.057 · DOI
- 10.1124/mol.61.3.667 · doi:10.1124/mol.61.3.667
- 10.1091/mbc.e08-06-0587 · DOI · Paper page
- 10.1042/BJ20081847 · DOI · Paper page
- 10.1083/jcb.144.5.857 · DOI · Paper page
- 10.1074/jbc.C000822200 · doi:10.1074/jbc.c000822200
- 10.1152/ajpcell.00075.2005 · DOI
- 10.2174/1874192400802010031 · DOI
- 10.1016/j.ymgme.2007.02.003 · DOI
- 10.1074/jbc.M112377200 · DOI
- Grover A. K., 1992, Peroxide inactivates calcium pumps in pig coronary artery, Am. J. Physiol., 263, H537
- 10.1152/ajpcell.1988.255.3.C297 · DOI
- 10.1016/S0161-5890(01)00108-0 · DOI · Paper page
- 10.1161/CIRCRESAHA.108.188441 · DOI
- 10.1038/nm1119 · DOI · Paper page
- 10.1016/S1471-4892(01)00032-7 · DOI · Paper page
- 10.1016/j.bbrc.2005.02.112 · DOI
- 10.1007/s00424-007-0429-6 · DOI
- 10.1083/jcb.200307010 · DOI · Paper page
- 10.1083/jcb.149.6.1235 · DOI · Paper page
- 10.1083/jcb.142.4.963 · DOI · Paper page
- 10.1074/jbc.M202405200 · DOI · Paper page
- 10.1016/S0167-4781(96)00133-9 · doi:10.1016/s0167-4781(96)00133-9
- 10.1016/S0014-5793(00)01666-5 · DOI
- 10.1074/jbc.M101229200 · DOI
- 10.1093/hmg/8.9.1621 · DOI
- 10.1016/0014-5793(95)01370-9 · DOI
- Cheatham B., 1995, Insulin action and the insulin signaling network, Endocr. Rev., 16, 117
- 10.1038/377173a0 · DOI · Paper page
- 10.1016/S0021-9258(17)42297-6 · DOI · Paper page
- 10.1073/pnas.92.3.664 · DOI · Paper page
- 10.1074/jbc.273.19.11548 · DOI · Paper page
- 10.1074/jbc.273.45.29686 · DOI
- 10.1074/jbc.272.38.23696 · DOI
- 10.1042/bj3190521 · DOI
- 10.1074/jbc.274.25.18067 · DOI
- 10.1074/jbc.M209521200 · DOI
- 10.2337/diabetes.51.2007.S427 · DOI
- 10.2337/diabetes.53.6.1517 · DOI
- 10.1021/bi001260w · DOI
- Roe M. W., 1994, Defective glucose‐dependent endoplasmic reticulum Ca2+ sequestration in diabetic mouse islets of Langerhans, J. Biol. Chem., 269, 18279, 10.1016/S0021-9258(17)32299-8 · DOI
- 10.1007/s001250051298 · doi:10.1007/s001250051298
Cited by
Patel, B. B., Raad, M., Sebag, I. A., & Chalifour, L. E. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft026 · Cited by 114
Larsen, E. K., Weber, D. K., Wang, S., Gopinath, T., Blackwell, D. J., Dalton, M. P., Robia, S. L., Gao, J., & Veglia, G. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.183034 · Cited by 15
Metadata
- Authors
- Vandecaetsbeek, I., Raeymaekers, L., Wuytack, F., & Vangheluwe, P.
- Venue
- BioFactors
- Publisher
- Wiley
- Published
- 2009-11
- Volume
- 35
- Issue
- 6
- Pages
- 484-499
- ISSN
- 0951-6433
- 1872-8081
- Cited by
- 41
- References
- 13
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factors controlling the activity of the SERCA2a pump in the normal and failing heart. https://app.cochat.ai/papers/10.1002/biof.63
- The paper
- Vandecaetsbeek, I., Raeymaekers, L., Wuytack, F., & Vangheluwe, P. (2009). Factors controlling the activity of the SERCA2a pump in the normal and failing heart. BioFactors. https://doi.org/10.1002/biof.63
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.